文献速递乳房整形与再造创面修复

乳房假体包膜内EBV相关弥漫大B细胞淋巴瘤:首例报告

Epstein-Barr Virus-associated Diffuse Large B-cell Lymphoma Identified in a Breast Implant Capsule: A New Breast Implant-Associated Lymphoma?
PubMed 文献 · Ann Plast Surg · 2021-01-01

本文报告一例51岁女性在二次乳房假体翻修手术时,于左乳假体周围包膜内发现EBV相关弥漫大B细胞淋巴瘤(EBV-DLBCL),距初次 cosmetic 隆乳21年。病理及免疫组化确诊B细胞淋巴瘤,EBER原位杂交阳性,分期检查无转移。患者拒绝取出假体,选择观察等待,诊断后2年无病生存。这是全球首例假体包膜内EBV相关弥漫大B细胞淋巴瘤报告。

要点

  • 乳房假体包膜内可发生EBV相关弥漫大B细胞淋巴瘤,非仅间变性大细胞淋巴瘤。
  • 假体周围包膜切除标本应行病理、免疫组化及EBER检测以明确淋巴瘤类型。
  • 本例患者拒绝取出假体,观察等待2年无病生存,但非推荐标准处理。

核心结论

  • 首次报告乳房假体包膜内发生EBV相关弥漫大B细胞淋巴瘤,扩展了乳房假体相关淋巴瘤的谱系。

研究设计与样本

  • 单例病例报告:51岁女性, cosmetic 隆乳21年后因反复严重包膜挛缩行二次翻修时发现左乳假体周围包膜病变。

主要发现

  • 包膜切除标本病理及免疫组化确诊B细胞淋巴瘤,EBER原位杂交阳性。
  • PET-CT分期未发现转移性疾病。
  • 患者拒绝取出新假体,选择观察等待,诊断后2年无病生存。

临床怎么用

  • 对乳房假体包膜病变应行充分病理评估包括EBER检测,以识别罕见淋巴瘤类型。
  • 确诊后多学科评估,取出假体与观察等待的决策需个体化。

局限性

  • 单例报告,证据级别低,不能推广诊疗标准。
  • 随访仅2年,长期结局未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast implant-associated anaplastic large cell lymphoma is a relatively uncommon T-cell lymphoma with about 900 reported cases worldwide to April 2020 according to the American Society of Plastic Surgeons Breast Implant-Associated Anaplastic Large Cell Lymphoma Physician Resources information. CASE PRESENTATION: A 51-year old woman was found to have an Epstein-Barr virus-related diffuse large B-cell lymphoma (EBV-DLCBCL) in her left breast periimplant capsule at the time of a second revision breast implant surgery for recurrent severe capsular contractures following cosmetic breast augmentation 21 years previously. The first revision operation, 15 years earlier, had comprised simple implant exchange from smooth-saline to textured-silicone gel prostheses. RESULTS: Histopathological and immunohistochemical analyses of the periimplant capsulectomy specimen confirmed a B cell lymphoma which was, in addition, positive for EBV-encoded RNA on in-situ hybridization. Staging investigations including positron emission tomography-computed tomography did not reveal any metastatic disease. DISCUSSION AND CONCLUSION: Despite recommendations to the contrary (by 2 independent hematological malignancy multidisciplinary teams), the patient has declined explantation of her new breast implants choosing instead to be observed under a watch-and-wait protocol. She remains disease-free 2 years postdiagnosis. To date, a diffuse B-cell lymphoma has never been documented as arising in a breast implant capsule or in association with breast augmentation whether associated with EBV or not. This is the first such report in the world.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Malata CM, Madada-Nyakauru RN, Follows G, et al. Epstein-Barr Virus-associated Diffuse Large B-cell Lymphoma Identified in a Breast Implant Capsule: A New Breast Implant-Associated Lymphoma? Ann Plast Surg. 2021. PMID: 33720919. doi:10.1097/SAP.0000000000002537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。